Valiant Laboratories

Valiant Laboratories EBIT per Share

The EBIT per Share of Valiant Laboratories (VALIANTLAB.NS) as of Nov 4, 2026 is 0.49 INR. In the previous year, EBIT per Share was 3.28 INR — a change of -85.02% (lower).

EBIT per Share

0.49INR

YoY

-85.02%

Last updated:

EBIT per Share of Valiant Laboratories is 2026 0.49 INR. EBIT per Share of Valiant Laboratories was 2025 3.28 INR. It decreases by -85.02% lower compared to the previous year.

The Valiant Laboratories EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
8.73 INR
Jan 1, 2022
9.21 INR
Jan 1, 2023
7.93 INR
Jan 1, 2024
1.67 INR
Jan 1, 2025
3.28 INR
Jan 1, 2026
0.49 INR
The Valiant Laboratories EBIT per Share history
YEAREBIT per ShareYoY
0.49INR-85.02%
3.28INR+96.28%
1.67INR-78.92%
7.93INR-13.83%
9.21INR+5.51%
8.73INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Laboratories Stock analysis

What does Valiant Laboratories do? Valiant Laboratories Ltd manufactures paracetamol API/bulk drug for pharmaceutical applications, targeting medical conditions such as headache, muscle ache, arthritis, back ache, toothache, cold, and fever. The company operates a single manufacturing facility at Tarapur industrial estate, approximately 150 km from Nhava Sheva Port (JNPT), producing specialty chemicals and pharma intermediates for domestic and international markets. Its subsidiary, VALIANT ADVANCED SCIENCES PRIVATE LIMITED, supports the company's operations in the pharmaceutical sector. The firm's primary revenue comes from selling paracetamol API and specialty chemicals to pharmaceutical companies and distributors globally. Manufacturing focuses on high-demand applications like pain relief and fever treatment, with products distributed across India and abroad. The company leverages its Tarapur facility's proximity to Nhava Sheva Port for efficient export logistics. Valiant Laboratories Ltd serves the pharmaceutical industry by supplying essential active ingredients, particularly paracetamol, which is widely used in over-the-counter medications. The company's manufacturing capabilities for specialty chemicals and pharma intermediates cater to both domestic and international clients seeking reliable API sources. Its single-location production model ensures focused resource allocation for consistent output quality. Valiant Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Laboratories stock

EBIT per Share of Valiant Laboratories is 0.49 INR in 2026.

EBIT per Share of Valiant Laboratories changed from 3.28 INR to 0.49 INR, representing a -85.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Valiant Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Valiant Laboratories

All Key Metrics — Valiant Laboratories